Halma (LON:HLMA) Earns Buy Rating from UBS Group

Halma (LON:HLMA)‘s stock had its “buy” rating reaffirmed by UBS Group in a research note issued on Friday,London Stock Exchange reports. They currently have a £47,750 target price on the stock.

Separately, Shore Capital Group reissued a “hold” rating on shares of Halma in a report on Monday, April 13th. Five investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of £5,338.78.

Halma Price Performance

Shares of LON HLMA opened at GBX 4,724 on Friday. Halma has a twelve month low of GBX 2,944 and a twelve month high of GBX 4,902. The company has a current ratio of 2.18, a quick ratio of 1.51 and a debt-to-equity ratio of 43.44. The company has a market capitalization of £17.84 billion, a price-to-earnings ratio of 51.66, a PEG ratio of 2.93 and a beta of 0.96. The firm has a 50-day moving average of GBX 4,356.13 and a two-hundred day moving average of GBX 3,918.87.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.